Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection
- PMID: 1545130
Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection
Abstract
Mice vaccinated with outer surface protein A (OspA) from Borrelia burgdorferi strain N40 are protected from challenge with an intradermal syringe inoculum of B. burgdorferi strains N40, B31, and CD16. Vaccination experiments were done to determine if protection extended to strains 297 and 25015. We now show that OspA-N40 immunized mice are protected against challenge with strain 297, isolated from the cerebrospinal fluid of a patient with neuroborreliosis, but not against challenge with strain 25015, isolated from a tick in Millbrook, NY. The OspA gene from strain 25015 was therefore cloned and sequenced. The deduced OspA-25015 protein sequence differs from OspA-N40 at 40 of 273 amino acids. Furthermore, mice vaccinated with rOspA-25015 are protected from challenge with strain 25015 but not against strain N40. The results extend the usefulness of OspA as a vaccine candidate, but indicate that OspA can vary among strains of B. burgdorferi and that vaccination of mice with OspA-N40 does not protect against intradermal challenge with an inoculum of 10(4) strain 25015 spirochetes.
Similar articles
-
Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.Eur J Immunol. 1996 Dec;26(12):2831-40. doi: 10.1002/eji.1830261206. Eur J Immunol. 1996. PMID: 8977275
-
T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.Eur J Immunol. 1997 Nov;27(11):2942-7. doi: 10.1002/eji.1830271129. Eur J Immunol. 1997. PMID: 9394822
-
Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo.Eur J Immunol. 1996 Nov;26(11):2749-57. doi: 10.1002/eji.1830261130. Eur J Immunol. 1996. PMID: 8921965
-
A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.Immunol Today. 1991 Jan;12(1):11-6. doi: 10.1016/0167-5699(91)90106-4. Immunol Today. 1991. PMID: 2015043 Review.
-
Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview.Infection. 1996 Mar-Apr;24(2):195-202. doi: 10.1007/BF01713339. Infection. 1996. PMID: 8740122 Review.
Cited by
-
Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection.Infection. 1992 Nov-Dec;20(6):342-9. doi: 10.1007/BF01710681. Infection. 1992. PMID: 1293055
-
Mixed infection of different Borrelia species among Apodemus speciosus mice in Hokkaido, Japan.J Clin Microbiol. 1995 Feb;33(2):490-2. doi: 10.1128/jcm.33.2.490-492.1995. J Clin Microbiol. 1995. PMID: 7536218 Free PMC article.
-
Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.J Exp Med. 1995 Jan 1;181(1):215-21. doi: 10.1084/jem.181.1.215. J Exp Med. 1995. PMID: 7807004 Free PMC article.
-
Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.J Clin Invest. 2000 Aug;106(4):561-9. doi: 10.1172/JCI9427. J Clin Invest. 2000. PMID: 10953031 Free PMC article.
-
Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species.Med Microbiol Immunol. 1995 Aug;184(2):73-80. doi: 10.1007/BF00221390. Med Microbiol Immunol. 1995. PMID: 7500914
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical